RIPK1 and hepatocellular carcinoma: Mice lacking NEMO in their liver parenchymal cells spontaneously develop steatohepatitis and hepatocellular carcinoma (HCC), and NEMO prevents hepatocarcinogenesis by inhibiting the RIP1 kinase activity-driven hepatocyte apoptosis through NF-κB-dependent and independent functions [166].